Well Told Grants

Federal grant recipients / Delaware

Federal grants to Sansimeon, Inc.

Wilmington, Delaware · Small businesses · UEI UZLEERAK1C93

Sansimeon, Inc. in Wilmington, Delaware received $1.6 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Biomedical Research and Research Training, with $1.2 million. In fiscal 2025 it was awarded $938,335.

From USAspending.gov award records, updated October 31, 2026.

By year

Federal grants to Sansimeon, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20210$0
FY 20220$0
FY 20231$275,628
FY 20241$399,369
FY 20251$938,335

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Sansimeon, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Biomedical Research and Research Training 93.8592$1.2 million
Human Genome Research 93.1721$399,369

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services3$1.6 million

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
A uniquely scalable platform for sequencing tens of millions of single cells from complex clinical samples with a streamlined workflow - project summary/abstract single-cell sequencing (sc-seq) has revolutionized our understanding of cellular heterogeneity, gene expression, and disease mechanisms. H
ASST_NON_R44GM149003_075 on USAspending
Biomedical Research and Research TrainingAugust 8, 2025$938,335
A uniquely scalable approach to single cell sequencing for the development of next generation cell therapies - immunotherapies (including car-t cell therapies) are wonder drugs when they work, but the response rates of today’s immunotherapies are only 15-20% and therapy costs remain prohibitively hi
ASST_NON_R43HG013446_075 on USAspending
Human Genome ResearchFebruary 23, 2024$399,369
A uniquely scalable approach to sequence tens of millions of single cells without compromising performance - immunotherapies (including car-t cell therapies) are wonder drugs when they work, but the response rates of today’s immunotherapies are only 15-20% and therapy costs remain prohibitively high
ASST_NON_R43GM149003_075 on USAspending
Biomedical Research and Research TrainingJuly 26, 2023$275,628

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Sansimeon, Inc. get?

$1.6 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Sansimeon, Inc. the most?

The Department of Health and Human Services, with $1.6 million in 3 awards.

What is Sansimeon, Inc.'s largest federal grant?

$938,335 under Biomedical Research and Research Training, with its first action in the period on August 8, 2025. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Sansimeon, Inc.?

Its largest are Biomedical Research and Research Training and Human Genome Research.

Other grant recipients in Wilmington

Largest federal grant recipients in Delaware · Federal grants in Delaware